You are here

The programme is an ESO recommended activity and is held with the support of

About the SIOG Advanced Course

The SIOG Advanced Course in Geriatric Oncology is our unique CME accredited training programme lead by international experts in the field of geriatrics AND oncology designed to provide specific skills in assessment, care pathways and therapeutic choices about the elderly patients with cancer in order to provide the basis of the assessment and the multi-dimensional approach that should be applied to elderly cancer patients.

This 2-phase advanced course is addressed to professionals in the management of elderly cancer patients who will acquire knowledge on the general principles of cancer treatment as a multidisciplinarity with case based programmes, discussions and debates in geriatrics for clinical oncologists as well as in clinical oncology for geriatricians.

Course dates

Phase 1 - 3 1/2-day course in Treviso, Italy from June 27-30, 2018
Phase 2 - this phase consists in attending the SIOG 2018 Annual Conference in Amsterdam from November 16-18, 2018

University Certificate will be provided to students only at the end of phase II on the proviso of attendance to both phases. 

Academic year: 2018


Location of the course

Phase 1 - Università Cattolica del Sacro Cuore - Centro Studi Achille e Linda Lorenzon - Viale Guglielmo Oberdan 5, 31100 Treviso, Italy
Phase 2 – RAI Amsterdam, Entrance E - Forum Centre, Europaplein 2-22, 1078 GZ Amsterdam, The Netherlands

Purpose of the course

The course aims are:

  1. To provide basic information related to cancer medicine to the geriatricians and to the application of geriatric principles to the clinical oncologists
  2. To train young medical oncologists and geriatricians to work together. These individuals will become the bridge between the oncological and geriatric teams in their own institutions

The course is addressed at:

  • Medical oncologists completing their training since less than 5 years and medical oncology fellows
  • Other clinical oncologists: surgical oncologists and radiotherapists completing their training since less than 5 years and radiotherapy fellows
  • Geriatricians completing their training since less than 5 years and geriatric fellows

To register your interest and for further information please do not hesitate to contact: SIOG Head Office at

November 16, 2017 - the following article "Tumour boards in geriatric oncology" was  published in Age and Ageing (Bristish Geriatrics Society) and was based on contributions of several faculty members of the SIOG 2017 Advanced Course.
November 02, 2017 - 
an article on "A contribution to the future of geriatric oncology training: The SIOG Treviso advanced course" was published in the JGO. The article was written by Giuseppe Colloca and Silvio Monfardini.
October 05 , 2017 - an article on "The SIOG Treviso course: Students' perspective" was published in JGO. This article was written by two students who participated in this course in 2016.

This is why people want to attend the SIOG Advanced Course in Geriatric Oncology

The programme is an ESO recommended activity and is held with the support of

Course programme

The course consists in a common part addressed to both clinical oncologists and geriatricians and two other successive parts for clinical oncologists on one side and on the other side for geriatricians. Case presentation and discussion are in common.
The course faculty will take care of the case selection and their presentations, subdivision of the participants in 4 small groups, and to follow their internal analysis of the case, before presentation of the conclusions in the general discussion.
The faculty are continuously present during the course and remain available as individual mentors, if requested, during the course and thereafter to determine whether there has been development of multidisciplinary treatment teams in each participant's institution within one year and vitality of these teams at five years.



The course programme (pdf) Version dated March 03, 2018


Day-to-day programme

Day 1 - Wednesday, June 27, 2018

12:30-14:00 - Registration and light welcome lunch

14:00-14:30 - Student self-introduction and course aims - Silvio Monfardini (IT) and Etienne Brain (FR)

14:30-16:00 - General concepts part 1
Chairs: Lodovico Balducci (US) and Shane O'Hanlon (IE)
14:30-15:00 - What should the Medical Oncologist ask the Geriatrician and possibly expect - Etienne Brain (FR)
15:00-15:30 - What should the Geriatrician ask the Medical Oncologist and possibly expect - Siri Rostoft (NO)
15:30-16:00 - Questions and answers

16:00-16:30 - Coffee break 

16:30-18:00 - General concepts part 2
Chairs: Tanya Wildes (US) and Marije Hamaker (NL)
16:30-17:30 - Multidisciplinarity in the older cancer patient: the example of rectal carcinoma - Isaaco Montroni (IT), Anita O’Donovan (IE), Martine Extermann (US) and Giuseppe Colloca (IT)
17:30-18:00 - The multidisciplinary team organisation for older cancer patients: portrait of geriatric oncology programmes worldwide - Silvio Monfardini (IT) and Pierre Soubeyran (FR)

18:00-19:00 - Welcome drink with students and faculty


Day 2 - Thursday, June 28, 2018

Geriatrics for clinical oncologists
Chairs: Giuseppe Colloca (IT) and Tanya Wildes (US)

Clinical oncology for geriatricians
Chairs: Martine Extermann (US) and Isaaco Montroni (IT)

08:00-08:30 - Biology of age and frailty - Giuseppe Colloca (IT) and Marije Hamaker (NL)
08:30-09:30 - Comprehensive geriatric assessment, screening and geriatric interventions - Siri Rostoft (NO) and Pierre Soubeyran (FR)

09:30-10:00 - Coffee break 

10:00-10:30 - Polypharmacy - Marije Hamaker (NL)
10:30-12:00 - Geriatric syndromes - Shane O‘Hanlon (IE) and Giuseppe Colloca (IT)

08:00-08:30 - Biology of cancer and omics - Etienne Brain (FR)
08:30-09:00 - General strategy of cancer treatments and evaluation of response - Lodovico Balducci (US)
09:00-09:30 - General principles of chemotherapy - Silvio Monfardini (IT)

09:30-10:00 - Coffee break 

10:00-10:30 - General principles of endocrine therapy & of specific molecular targeted therapy - Antonella Brunello (IT)
10:30-11:00 - General principles of immunotherapy - Andrea Luciani (IT)
11:00-11:30 - General principles of surgical oncology - Kwok-Leung Cheung (GB)
11:30-12:00 - General principles of radiotherapy - Anita O’Donovan (IE)

12:00-13:00 - Lunch break

13.00-15:00 - Management of prostate cancer in older vulnerable/frail patients
13:00-13:10 - Case presentation 1: A case of localized prostate cancer - Marije Hamaker (NL)
13:10-13:20 - Case presentation 2: A case of metastatic prostate cancer - Andrea Luciani (IT)
13:20-14.40 - Working groups (30’) followed by individual presentations by working groups, debate and conclusions (50’)
14.40-15:00 - Key issues - Martine Extermann (US)

15:00-15.30 - Coffee break

15:30-17:30 - Management of haematological malignancies in older vulnerable/frail patients
15.30-15.40 - Case presentation 1: A case of diffuse large B-cell lymphoma - Pierre Soubeyran (FR)
15.40-15.50 - Case presentation 2: A case of multiple myeloma - Siri Rostoft (NO) and Tanya Wildes (US)
15-50-17.10 - Working groups (30’) followed by individual presentations by working groups, debate and conclusions (50’)
17:10-17.30 - Key issues - Tanya Wildes (US)

17:30-18:30 - Surgery and Radiotherapy in older vulnerable/ frail patients
Chairs: Stuart Lichtman (US) and Etienne Brain (FR)
17:30-17:50 - The practice of surgery in older cancer patients - Isaaco Montroni (IT)
17:50-18:10 - The practice of anaesthesiology in older cancer patients - Troy Wildes (US)
18:10-18:30 - The practice of radiotherapy in older cancer patients - Anita O’Donovan (IE)


Day 3 - Friday, June 29, 2018

08:00-10:00 - Supportive care
Chairs: Lodovico Balducci (US) and Siri Rostoft (NO)
08:00-08:30 - Supportive care issues - Stuart Lichtman (US)
08:30-09:00 - Prehabilitation and rehabilitation - Kwok-Leung Cheung (GB) and Giuseppe Colloca (IT)
09:00-09:30 - Cancer and no cancer pain in the elderly - Giuseppe Colloca (IT)
09:30-10:00 - Prediction and possible reduction of toxicity of chemotherapy in older patients - Martine Extermann (US)

10:00-10:30 - Coffee break

10.30-12.30 - Management of primary and advanced breast cancer in older vulnerable/frail patients
10:30-10:40 - Case presentation 1: A case of localized breast cancer - Antonella Brunello (IT) and Kwok-Leung Cheung (GB)
10:40-10:50 - Case presentation 2: A case of advanced breast cancer - Giuseppe Colloca (IT) and Etienne Brain (FR)
10:50-12:10 - Working groups (30’) followed by individual presentations by working groups, debate and conclusions (50’)
12:10 -12:30 - Key issues - Etienne Brain (FR)

12:30-13:30 - Lunch break

13:30-15:30 - Management of lung cancer in older vulnerable/frail patients
13:30-13:40 - Case presentation 1: A case of localized Non-Small Cell Lung Carcinoma - Anita O’Donovan (IE) and Giuseppe Colloca (IT)
13:40-13:50 - Case presentation 2: A case of advanced Non-Small Cell Lung Carcinoma - Shane O'Hanlon (IE) and Andrea Luciani (IT)
13:50-15:10 - Working groups (30’) followed by individual presentations by working groups, debate and conclusions (50’)
15:10-15:30 - Key issues - Stuart Lichtman (US)

15:30-16:00 - Coffee break

16:00-17:00 - Clinical research in Geriatric Oncology
Chairs: Antonella Brunello (IT) and Tanya Wildes (US)
16:00-16:30 - Interpretation oftrials - Marije Hamaker (NL) and Martine Extermann (US)
16:30-17:00 - How to set-up and run a clinical trial - Pierre Soubeyran (FR) and Marije Hamaker (NL)

17:00-18:00 - Difficult cases submitted by students - Lodovico Balducci (US), Shane O'Hanlon (IE), Isaaco Montroni (IT) and Anita O’Donovan (IE)

18:00-20:00 - Farewell drink and dinner


Day 4 - Saturday, June 30, 2018

08:00-10:00 - Management of colorectal cancer in older vulnerable/frail patients
08:00-08:10 - Case presentation 1: A case of advanced colon cancer - Siri Rostoft (NO) and Andrea Luciani (IT)
08:10-08:20 - Case presentation 2: A case of localized colon cancer - Isaaco Montroni (IT)
08:20-09:40 - Working groups (30’) followed by individual presentations by working groups, debate and conclusions (50’)
09:40-10:00 - Key issues - Etienne Brain (FR)

10:00-10:30 - Coffee break

10:30-12:30 - Difficult cases submitted by students - Silvio Monfardini (IT) Siri Rostoft (NO), Isaaco Montroni (IT) and Anita O’Donovan (IE)

12:30-13:00 - Evaluation and conclusion of the course - Silvio Monfardini (IT), Etienne Brain (FR) and Giuseppe Colloca (IT)






Under the auspices of

ASCO® is a registered trademark of the American Society of Clinical Oncology®. Used with permission. This is not an ASCO sponsored event.

The programme is an ESO recommended activity and is held with the support of

Scientific programme committee

Course director
Silvio Monfardini (IT)
Etienne Brain (FR)
Course coordinator
Giuseppe Colloca (IT)
Martine Extermann (US)
Pierre Soubeyran (FR)
Tanya Wildes (US)
Laurence Verhagen (CH) – ex-officio
Honorary members
Riccardo Audisio (GB)
Lodovico Balducci (US)


Course faculty list Faculty

Lodovico Balducci (US)Silvio Monfardini (IT)
Etienne Brain (FR)Isacco Montroni (IT)
Antonella Brunello (IT)Anita O'Donovan (IE)
Kwok-Leung Cheung (UK)Shane O'Hanlon (IE)
Giuseppe Colloca (IT)Siri Rostoft (NO)
Martine Extermann (US)Pierre Soubeyran (FR)
Marije E Hamaker (NL)Tanya Wildes (US)
Stuart Lichtman (US)Troy Wildes (US)
Andrea Luciani (IT)


Course faculty brief profiles and pictures

Lodovico Balducci

H. Lee Moffitt Cancer Center and University of South Florida, Tampa (US)

Lodovico Balducci graduated from the Universita Cattolica del Sacro Cuore, Rome, Italy in 1968. Following a fellowship at the A. Gemelli General Hospital, Rome he moved to the US to complete a residency at the University of Mississippi Medical Center. Dr Balducci is currently Director of the Division of Geriatric Oncology at the Moffitt Cancer Center and Professor of Oncologic Sciences and Medicine and the University of South Florida in Tampa, Florida where he specialises in Hematology/Oncology and Medical Oncology. Dr Balducci’s research focuses on cancer and aging, which he has extended to three other areas: determination of life-expectancy and active life expectancy, polypharmacy in older cancer patients, and support of the caregiver. In addition, Dr Balducci has been involved in cooperative trials involving management of breast, lung, colorectal and prostate cancer.


Etienne Brain

Institut Curie - Hôpital René Huguenin, St. Cloud (FR)

Etienne GC Brain, MD PhD, has been working since 1998 as a medical oncologist at the Hôpital René Huguenin (Saint-Cloud, France), which is now part of the academic centre Institut Curie. He obtained both his MD and PhD from University Paris V René Descartes after leading works in preclinical and clinical pharmacology on alkylating agents in Boston (Dana Farber Cancer Institute and Boston University). He was the Deputy Director for Research at Centre René Huguenin from 2008-2009, until the merge with Institut Curie happened in 2010, making this "multi-sites” institution one of the largest one dedicated to breast cancer management in Europe.
Etienne GC Brain is the secretary of the Breast Cancer Group of EORTC and chairs the GERICO group (clinical research in geriatric oncology) at UNICANCER. He is very committed to clinical research, involved in many trials covering breast cancer and geriatric oncology. His most recent interest focuses on competing risks for mortality in older breast cancer patients, trying to better define the indication of systemic treatment in adjuvant setting, and is embodied in the national program ASTER 70s granted in 2011 by the French health ministry. He is (co)author of several publications in peer-reviewed journals, including the JAMA, Lancet Oncol and J Clin Oncol.
He is member of the Editorial Board of the J Geriatric Oncol. He is an active member of ASCO and ESMO. He is the current president of SIOG.


Antonella Brunello

Istituto Oncologico Veneto, Padova (IT)

I am full time consultant at the Division of Medical Oncology 1 at the Istituto Oncologico Veneto in Padova.
I specialized in Medical Oncology in 2008 and I am currently attending the Ph.D Programme in Oncology and Oncological Surgery at the University of Padova. I was an International Visiting Scholar at the Moffit Cancer Center – Senior Adult Oncology Program in the years 2006-2007.
Over my career, I have been committed to medical treatment and clinical research of solid tumors, with particular interest in cancer in the elderly, breast cancer and sarcoma.
I am currently involved as either principal investigator or co-investigator in clinical and translational research projects in oncogeriatric trials.
I authored more than 30 papers in peer-reviewed journals, most of them about breast cancer, sarcoma and cancer in the elderly.
I am serving as scientific secretary of the Hematological Toxicity Guidelines board of the Italian Association of Medical Oncology (AIOM) since 2012.
I am a current member of national and international scientific societies, among which AIOM, ESMO, ASCO, SIOG and I am a board member of the Veneto Regional Section of AIOM, and of the Italian Group for Geriatric Oncology (GioGer).


Kwok-Leung Cheung

School of Medicine, University of Nottingham Consultant Breast Surgeon, Royal Derby Hospital, (UK)

Mr Cheung qualified and trained at Queen Mary Hospital, Hong Kong. Upon completion of general surgery training, he conducted clinical and laboratory research at the University of Nottingham, UK, with a Doctor of Medicine (in the area of blood tumour markers) awarded in 2001.  He was then appointed as Consultant Breast Surgeon at Nottingham University Hospitals where he served as Head of Service, Breast Services (2007 - 2010) and Lead Clinician for Breast Cancer (2007 - 2011).  Mr Cheung joined the University of Nottingham as Clinical Associate Professor in 2004. He is also currently Consultant Breast Surgeon at Royal Derby Hospital.
He has obtained surgical fellowship status from Hong Kong, Edinburgh and America. Mr Cheung was selected as one of the 12 International Guest Scholars 2007 of the American College of Surgeons, as a recognition of his strong interests and commitment in teaching and research.
Mr Cheung is a member of the Faculty of Examiners for Intercollegiate MRCS and the Panel of Examiners of the Intercollegiate Specialty Board in General Surgery. Mr Cheung is also part of the National Cancer Peer Review team and an External Professional Advisor to the Parliamentary Health Service Ombudsman. He is a member of the American Society of Clinical Oncology, European Society of Breast Cancer Specialists, British Association of Cancer Surgery, Association of Breast Surgery, British Breast Group and International Society of Geriatric Oncology (SIOG). In 2015, he received the National Representative of the Year award from SIOG recognising his commitments to geriatric oncology and SIOG. Within SIOG, he currently serves as the UK National Representative, Chair of the Membership and National Representatives Committee, a member of the Surgical Task Force, the Executive Committee and the Board.
His research interests include breast cancer, surgery and non-operative therapies, endocrine and targeted therapies, and clinical trials. He leads a research programme on primary breast cancer in older women at the University of Nottingham, covering biology and clinical outcome, geriatric assessment and psychosocial aspects, and cost effectiveness of different therapeutic strategies. In 2010, Mr Cheung pioneered the Symposium on Primary Breast Cancer in Older Women in the UK, which has now become a biennial event, hosted by the University under the auspices of SIOG. Mr Cheung has published over 100 journal articles, in addition to a number of book chapters and meeting abstracts.


Giuseppe Colloca

Policlinico A. Gemelli, Università Cattolica Sacro Cuore, Roma, (IT)

Giuseppe Colloca is a medical doctor at Policlinico A. Gemelli in Rome, Italy. Graduated in Medicine and Surgery at Catholic University of Sacred Heart of Rome in 2001, after a fellowship in Geriatric Medicine (2006) in the same University, he spent one year in Senior Adult Oncology Group at Moffitt Cancer Center, Florida US and then, in the Palliative Care Unit at  Fundacio’ Hospital Asil de Granollers, Barcellon Spain. In 2014 he completed his PhD in Geriatric-Oncology.  Member of InterRAI group about geriatric assessment tools, his research and clinical interest are on cancer assessment and pain management in the elderly.



Martine Extermann

H. Lee Moffitt Cancer Center, Tampa, (US)

Dr. Martine Extermann is Professor of Oncology and Medicine at the University of South Florida. She is the Interim Program Leader of the Senior Adult Oncology Program at the Moffitt Cancer Center. She earned her medical diploma and her medical PhD at the University of Geneva, Switzerland. She has a Swiss Board Certification in Internal Medicine, specialty Oncology-Hematology. She also holds ABIM certifications in Internal Medicine and Medical Oncology. She has worked at Moffitt since 1994 and has been a faculty member since 1997. Her research focuses on cancer in the elderly. Her main areas of investigation are comorbidity, comprehensive assessment, and prediction/prevention of treatment toxicity in older cancer patients.

She served as President of the International Society of Geriatric Oncology (SIOG), of which she is also a founding board member. She served or is serving on several ASCO Committees, and on the Editorial Board of the Journal of Clinical Oncology. Dr. Extermann was presented at ASCO 2009 with the B.J. Kennedy Award for Scientific Excellence in Geriatric Oncology. She also received the SIOG Paul Calabresi Award in 2014, and a Lifetime Achievement Award in Geriatric Oncology from the German Society of Geriatrics and German Society of Hematology/Oncology in 2015.


Marije E Hamaker

Department of Internal Medicine, Diakonessenhuis, Utrecht, (NL)

Marije Hamaker has been working as a clinical geriatrician working at the Diakonessenhuis in Utrecht, the Netherlands since 2010. In 2012, she defended her PhD thesis on “Decision making in geriatric oncology”. She has remained active in geriatric oncology research, focussing on treatment decisions and patient-centred outcome measures in various cancer types, and additionally has set up a project regarding geriatric nephrology in 2014. She is an active member of the Dutch Geriatric Oncology Foundation, the Elderly Task Force of the EORTC as well as a member of SIOG and the Dutch Geriatrics Society.



Stuart Lichtman

Memorial-Sloan-Kettering Cancer Center, Commack, NY, USA

Dr. Lichtman is an Attending Physician and Member, Memorial Hospital for Cancer and Allied Diseases, Member, Memorial Sloan-Kettering Cancer Center and Professor of Medicine, Weill Cornell Medical College. He is a member of the 65+ Clinical Geriatrics Program and Gynecologic Oncology Disease Management Team at the Center. He has been on the Board of Directors and Treasurer of SIOG since 2010 and has participated in multiple taskforces (Chemotherapy, as chair, Geriatric Assessment, Renal Dysfunction, Lymphoma, Oral Chemotherapy), US National Representative and Scientific Chair of the 2011 meeting. He has been a participant in the Alliance for Clinical Trials in Oncology (formerly CALGB) as a member of the Pharmacology and Experimental Therapeutics Committee (1990-2008), the Cancer in the Elderly Committee (1995-present). His work also included the Scientific Advisory Board of the Geriatric Oncology Consortium, the Elderly Taskforce of the Gynecologic Oncology Group, Cancer and Aging Research Group and the NCCN Guidelines Taskforce for the treatment, Evaluation of Older Women with Breast Cancer, Editorial Board of the Journal of Geriatric Oncology, External Advisory Board of the University of Iowa Cancer Center, Governing Board Cancer and the Kidney International Network. He has been a member of ASCO since 1988 and have been an active participant by serving on the Clinical Practice Committee, Scientific Program Committee, Geriatric Oncology Special Interest Group, an invited speaker at Educational Sessions, ASCO University, ASCO Post and a faculty member of the ASCO/AACR Vail Clinical Trials workshop for five sessions on the topic of special populations. He has been a guest editor for a special edition devoted to Geriatric Oncology for the Journal of Clinical Oncology (2007 and 2014). He has published over 100 articles in peer review journals, contributed to nine book chapters and edited three books and have been an invited speaker and many national and international meetings on Geriatric Oncology. In 2014 he received the ASCO BJ Kennedy Award for Scientific Excellence in Geriatric Oncology.


Andrea Luciani

The Ospedale S Paolo, Milan (IT)

Andrea Luciani, graduated in Medicine and Surgery at University of Milan. After the fellowship in medical oncology he spent some months in Senior Adult Oncology Group at Moffit Cancer Center, Florida US. When he returned to Italy he took the postdoctoral degree in Pharmacology and Metabolic disease. He is now an assistant physician in medical oncology department at S. Paolo University Hospital in Milan. He is the chairman of EORTC Cancer In the Elderly Task Force and the National Representative for Italy at International Society of Geriatric Oncology (SIOG). He has been the scientific secretary of the AIOM guidelines on elderly cancer patients from 2012 until present. His main interests are cancer in the elderly, with a special focus on lung and genitourinary cancer.


Silvio Monfardini

Instituto Palazzolo,Fondazione  Don Gnocchi, Milan (IT)

Present position: Director Geriatric Oncology Program Istituto Palazzolo, Fondazione Don Gnocchi, Milano, Italy.
Past positions:
Chief of the Division of Medical Oncology of the Istituto Oncologico Veneto of Padua
Scientific Director of the Istituto Nazionale per lo Studio e la Cura dei Tumori of  Naples
Scientific Director of the Centro di Riferimento Oncologico of Aviano
Dr. Silvio Monfardini is the author the main fields of Medical Oncology of 340 indexed publications, of whom 95 dedicated to Geriatric Oncology
Member of the American Society of Clinical Oncology since 1972
Past President of the European Society for Medical Oncology (ESMO)
Past President of the (Associazione Italiana di Oncologia Medica (AIOM)
Past President of the “International Society of Geriatric Oncology” (SIOG)
Recipient in the year 2006 of the International Society of Geriatric Oncology “Paul Calabresi” Memorial lecture award and in 2015 of the B.J. Kennedy award for Geriatric Oncology 


Anita O'Donovan

Trinity College Dublin (IE)

Anita O'Donovan graduated with a BSc in Radiation Therapy from Trinity College Dublin (TCD) in 2002. She joined the Discipline of Radiation Therapy at TCD in 2011, as Assistant Professor, having previously worked in both clinical and research positions as a radiation therapist in Saint Luke’s Hospital, Dublin and Cork University Hospital. Her main research interest is geriatric oncology, more specifically geriatric assessment, education of oncology professionals, and the application of these measures in clinical practice.  As a starting point, Anita has conducted an international Delphi consensus study on geriatric assessment (GA) in Oncology, in close collaboration with Dr Supriya Mohile, geriatric oncologist, at the University of Rochester, who has undertaken a similar study from a US perspective.  The main focus of Anita’s research is the application of GA in radiotherapy clinical practice and outcomes of older cancer survivors in Ireland.
Anita is part of the TCD Ageing Theme Steering Committee, led by Professor Rose Anne Kenny, representing the theme “Cancer and Ageing”.  One of the main aims of this research centre is to optimise opportunities for collaborative research between different disciplines. Ageing research is a main focus of TCD’s strategic plan, and is one of the major themes prioritised by the college.
Anita has a keen interest in older patient advocacy and incorporating “service learning” principles into her teaching, promoting intergenerational solidarity and the adoption of positive attitudes towards older people by future healthcare professionals.  She is also involved in educational outreach for older people through liaison with Age Action Ireland.


Shane O'Hanlon

St Vincent's University Hospital, Dublin, Ireland

Dr Shane O'Hanlon is a Consultant Physician in Geriatric Medicine at St. Vincent's University Hospital, Dublin. He previously worked with the Macmillan funded project Comprehensive Care for Older People with Cancer at the Royal Berkshire Hospital, Reading. He is a faculty member of the Irish Geriatric Oncology meeting and teaches regularly on geriatric oncology for multidisciplinary staff. He has been an invited speaker at geriatric oncology meetings in several countries. He is the Honorary Secretary of the British Geriatrics Society.



Siri Rostoft

University of Oslo, Norway & City of Hope, Duarte, CA, USA

Siri Rostoft is a medical doctor at Oslo University Hospital, Norway, specialized in internal medicine and geriatric medicine. She completed her PhD about geriatric assessment in older surgical cancer patients in 2011. Her main research interests in geriatric oncology are the clinical importance of geriatric assessment and interventions and frailty. She is a deputy editor for Journal of Geriatric Oncology.




Pierre Soubeyran

Institut Bergonie, Bordeaux (FR)

Pierre Soubeyran, M.D., Ph.D., is a Medical Oncologist at Institut Bergonié, Comprehensive Cancer Center in Bordeaux, and Professor of Medical Oncology at the University of Bordeaux. He is highly involved in the development of Geriatric Oncology at both the clinical (co-coordinator of the Coordination Unit of Geriatric Oncology of Aquitaine) and research level (President of the Scientific Council of the French Society of Geriatric Oncology (SoFOG) and Coordinator of the French Geriatric Oncology Cooperative Group DIALOG). He is also involved in cancer research as Director of the U1218 INSERM Cancer research unit and Director of the SIRIC, Center for Integrated Cancer Research of Bordeaux, named BRIO (Bordeaux Recherche Intégrée Oncologie).
He earned his Medical Degree from the University of Nantes in France and trained in Medical Oncology at the Institut Bergonié and University of Bordeaux. He completed a fellowship at the MD Anderson Cancer Center in Houston and later obtained his Ph.D. at the University of Bordeaux in the field of minimal residual disease in follicular lymphoma. An active researcher, Prof. Pierre Soubeyran’s clinical interests include clinical and biological research on lymphoma and geriatric oncology. He is leading trials focused on these topics as part of the French LYSA lymphoma Research Group and the French Geriatric Oncology Cooperative Group DIALOG. He is a member of ESMO, ASCO, ASH, SoFOG and SIOG. He has authored and co-authored numerous articles, book chapters and monographs on various aspects of cancer treatment.



Tanya Wildes

Washington University School of Medicine, St. Louis, MO (US)

Tanya M. Wildes, MD, MSCI is a geriatric oncologist and Assistant Professor of Medicine at Washington University School of Medicine. She completed fellowships in hematology, oncology and geriatrics at Washington University.  Her research and clinical interests focus on older adults with multiple myeloma.  She also studies prevention of falls in older adults with cancer.   She is a member of the Cancer and Aging Research Group, serves as an institutional representative on the National Comprehensive Cancer Network Older Adult Oncology Guidelines panel and is also an active member of SIOG, currently serving as Chair of the Science and Education Committee.

The programme is an ESO recommended activity and is held with the support of

CME accreditation and diploma

CME accreditation will be asked for the SIOG 2018 Advanced Course in Geriatric Oncology.

At the end of the course, in accordance with art. 6 of Law no. 341/1990, students will receive a certificate as provided by art. 2, paragraph 5, of Title I of the academic regulations of the University. In accordance with the programme of Continuing Medical Education, the students in a university course are exempted from acquiring the CME credits for the current year (or 50 CME credits).The Catholic University of the Sacred Heart reserves the right to not activate or cancel the course if it does not reach the coverage of expenses.

To obtain the final certification, students are required to attend at least 80% of the teaching and training and the successful completion of all course tests.

The programme is an ESO recommended activity and is held with the support of


Ideal profile of the advanced course candidate:

  • Medical oncologists and other clinical oncologists completing their training since less than 5 years and medical oncology fellows
  • Medical oncology fellows
  • Geriatricians completing their training since less than 5 years
  • Geriatric fellows
  • Fluency in English


Attendance to the course is limited to a maximum of 40 participants and admittance is by competitive application. All applications will be reviewed by the Course committee who will make the selection of the course participants based on their application. Successful applicants must pay the admission fee in order to be granted admission to the course be able to be present during the two phases of the course.

SIOG Member-  EUR 1,400.00
Non-SIOG Member - EUR 1,650.00

Fees include:

  • Teaching and course documents,
  • Lunches and coffee breaks during the course in Treviso,
  • Welcome lunch and farewell dinner,
  • Access to online course proceedings,
  • 1 year SIOG membership for 2018 for those who are not yet a SIOG member
  • Registration to SIOG 2018 Annual Conference - Amsterdam, Netherlands

Not included in the fees are the travel expenses to the course in Treviso and to the Annual Conference in Amsterdam, hotel accommodation, dinners in Treviso, any lunches and dinners during the Annual Conference and transfers.


Key dates

Admission process opens - January 8, 2018
Admission process closes -  February 9, 2018
Notification of acceptance - March 2018


How to apply

The admission process is NOW closed.

Next steps

-       All complete applications received by the deadline will be reviewed by the Course committee
-       All applicants will be informed about the outcome of the selection process in the beginning of March 2018
-       Successful applicants will have to pay their admission fee as marked above either by bank transfer or via PayPal
-       Once the payment has been received, applicants will receive their course confirmation along with all relevant course documents in due course

The programme is an ESO recommended activity and is held with the support of


PDF iconSIOG 2018 GO advance course industry flyer.pdf

Opportunities for industry partners for the SIOG 2018 Advanced Course edition

Oncologists and Geriatricians need to work together!

Support this unique training programme and help us achieve this goal. Here is how:
Download our leaflet and contact Sabrina Marchal at to discuss your participation.

Italian pharmaceutical companies

SIOG has chosen MCI Rome to collect - on behalf of SIOG - all applications from Italian pharmaceutical companies and file them with the appropriate Italian Health Ministry officials.

For further information and questions, please contact:
MCI Rome
Attn. Mrs Maria Grazia Paolelli
Via della Ferratella in Laterano 41
00184 Rome
T +39 06 70 49 5693
F +39 06 70 96 292